Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
4.170
-0.110 (-2.57%)
Nov 21, 2024, 4:00 PM EST - Market closed

Skye Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1273415251119
Upgrade
Market Cap Growth
135.06%126.97%-40.22%130.88%-42.17%-65.37%
Upgrade
Enterprise Value
63331716821
Upgrade
Last Close Price
4.282.724.0513.0010.0032.63
Upgrade
PB Ratio
1.71-15.76-4.924.2223.7933.83
Upgrade
P/TBV Ratio
1.56--4.2223.7933.83
Upgrade
Debt / Equity Ratio
0.00-2.16-0.660.363.320.71
Upgrade
Quick Ratio
11.990.140.122.303.141.88
Upgrade
Current Ratio
14.190.840.742.463.382.05
Upgrade
Return on Equity (ROE)
-54.82%--1364.20%-269.90%-1313.66%-
Upgrade
Return on Assets (ROA)
-30.39%-80.28%-120.69%-78.31%-168.39%-209.69%
Upgrade
Return on Capital (ROIC)
-35.95%-1159.18%-328.19%-98.60%-272.61%-
Upgrade
Earnings Yield
-16.47%-112.07%-131.64%-34.42%-61.18%5.67%
Upgrade
FCF Yield
-17.43%-41.57%-86.75%-26.52%-56.53%-32.51%
Upgrade
Buyback Yield / Dilution
-537.83%-215.43%-36.56%-75.70%-36.48%-39.95%
Upgrade
Total Shareholder Return
-537.83%-215.43%-36.56%-75.70%-36.48%-39.95%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.